Mutations in a genetic region that regulates RNA stability could influence prostate cancer outcomes and drug resistance, according to new work from scientists at Fred Hutchinson Cancer Center published in Cell Reports.
Aug 7, 2023
0
65
With cancer rates rising throughout sub-Saharan Africa—home to 1.1 billion people, or about 14% of the world's population—researchers with the Botswana-Rutgers Partnership for Health are seeking solutions.
Jul 18, 2023
0
1
Fifty percent of patients with metastatic prostate cancer experience some level of financial hardship due to their treatment, according to a study in the August issue of The Journal of Urology, an Official Journal of the ...
Jul 7, 2023
0
1
The National Comprehensive Cancer Network (NCCN)—an alliance of leading academic cancer centers—published survey results today that shed light on just how widespread the current platinum chemotherapy shortage is, and ...
Jun 7, 2023
0
0
Routine diagnostic analyses of mutations in cell-free DNA in patients with metastatic prostate cancer are now possible for the first time in Sweden. The test has been developed by researchers at Karolinska Institutet, and ...
Apr 27, 2023
0
0
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
Mar 28, 2023
0
17
Detailed PSMA PET mapping of cancer recurrence in the prostate bed shows that current radiotherapy contouring guidelines—which determine the target areas for treatment—miss a significant number of lesions and may irradiate ...
Mar 24, 2023
0
5
TALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progression or death by 37%.
Mar 17, 2023
0
6
Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation.
Mar 12, 2023
4
167
A new mathematical model which aims to optimize treatment for prostate cancer has been developed by experts at the University of Portsmouth.
Mar 1, 2023
0
1
